1
|
Fan F, Xu S, Guo M, Cai T. Effect of organic acids on the solid-state polymorphic phase transformation of piracetam. Int J Pharm 2023; 647:123532. [PMID: 37871868 DOI: 10.1016/j.ijpharm.2023.123532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2023] [Revised: 10/11/2023] [Accepted: 10/17/2023] [Indexed: 10/25/2023]
Abstract
Metastable polymorphs are frequently used in oral solid dosage forms to enhance the absorption of poorly water-soluble drug compounds. However, the solid phase transformation from the metastable polymorph to the thermodynamically stable polymorph during manufacturing or storage poses a major challenge for product development and quality control. Here, we report that low-content organic acids can exhibit distinct effects on the solid-state polymorphic phase transformation of piracetam (PCM), a nootropic drug used for memory enhancement. The addition of 1 mol% citric acid (CA) and tricarballylic acid (TA) can significantly inhibit the phase transformation of PCM Form I to Form II, while glutaric acid (GA) and adipic acid (AA) produce a minor effect. A molecular simulation shows that organic acid molecules can adsorb on the crystal surface of PCM Form I, thus slowing the movement of molecules from the metastable form to the stable form. Our study provides deeper insights into the mechanisms of solid-state polymorphic phase transformation of drugs in the presence of additives and facilitates opportunities for controlling the stability of metastable pharmaceuticals.
Collapse
Affiliation(s)
- Fanfan Fan
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, College of Pharmacy, China Pharmaceutical University, Nanjing 211198, China
| | - Shuyuan Xu
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, College of Pharmacy, China Pharmaceutical University, Nanjing 211198, China
| | - Minshan Guo
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, College of Pharmacy, China Pharmaceutical University, Nanjing 211198, China
| | - Ting Cai
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, College of Pharmacy, China Pharmaceutical University, Nanjing 211198, China; Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing 211198, China.
| |
Collapse
|
2
|
Park H, Kim JS, Hong S, Ha ES, Nie H, Zhou QT, Kim MS. Tableting process-induced solid-state polymorphic transition. JOURNAL OF PHARMACEUTICAL INVESTIGATION 2022. [DOI: 10.1007/s40005-021-00556-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
3
|
Bourduche F, Sanchez-Ballester NM, Bataille B, Lefèvre P, Sharkawi T. Structure-Property Relationship of Amorphous Maltitol as Tableting Excipient. AAPS PharmSciTech 2020; 21:281. [PMID: 33051782 DOI: 10.1208/s12249-020-01824-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2020] [Accepted: 09/14/2020] [Indexed: 11/30/2022] Open
Abstract
Maltitol shows interesting properties compared with mannitol or sorbitol, two other polyols, which are widely used as a pharmaceutical excipients for tablet compaction. For this study, the properties of an amorphous polyol, maltitol, were investigated using a tablet press simulator. The aim of this study was to evaluate the behavior of amorphous maltitol compared to SweetPearl® P 200, a pure product, and SweetPearl® P 300 DC, a textured crystalline maltitol excipient for direct compression. The physicochemical and pharmacotechnical properties were compared, revealing a major change in properties after amorphization. The study of the tabletability, mean yield pressure, elastic properties, etc. shows that the compression behavior of amorphous powders has been significantly altered. The results showed specific properties of amorphous maltitol with good tabletability at low compaction pressure. The stability of the amorphous and the evolution of its behavior in compression were then studied, showing a direct link between its recrystallization and the change in its properties. The use of a stabilizing agent, maltotriitol, slowed down the recrystallization, maintaining the specific properties of the amorphous material in compression for a longer period of time.
Collapse
|
4
|
Tian B, Ding Z, Zong S, Yang J, Wang N, Wang T, Huang X, Hao H. Manipulation of Pharmaceutical Polymorphic Transformation Process Using Excipients. Curr Pharm Des 2020; 26:2553-2563. [PMID: 32053064 DOI: 10.2174/1381612826666200213122302] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2019] [Accepted: 01/10/2020] [Indexed: 12/31/2022]
Abstract
BACKGROUND In the pharmaceutical field, it is vital to ensure a consistent product containing a single solid-state form of the active pharmaceutical ingredient (API) in the drug product. However, some APIs are suffering from the risk of transformation of their target forms during processing, formulation and storage. METHODS The purpose of this review is to summarize the relevant category of excipients and demonstrate the availability and importance of using excipients as a key strategy to manipulate pharmaceutical polymorphic transformation. RESULTS The excipient effects on solvent-mediated phase transformations, solid-state transitions and amorphous crystallization are significant. Common pharmaceutical excipients including amino acids and derivatives, surfactants, and various polymers and their different manipulation effects were summarized and discussed. CONCLUSION Appropriate use of excipients plays a role in manipulating polymorphic transformation process of corresponding APIs, with a promising application of guaranteeing the stability and effectiveness of drug dosage forms.
Collapse
Affiliation(s)
- Beiqian Tian
- National Engineering Research Center of Industrial Crystallization Technology, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China
| | - Zhiyong Ding
- National Engineering Research Center of Industrial Crystallization Technology, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China
| | - Shuyi Zong
- National Engineering Research Center of Industrial Crystallization Technology, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China
| | - Jinyue Yang
- National Engineering Research Center of Industrial Crystallization Technology, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China
| | - Na Wang
- National Engineering Research Center of Industrial Crystallization Technology, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China
| | - Ting Wang
- National Engineering Research Center of Industrial Crystallization Technology, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China
| | - Xin Huang
- National Engineering Research Center of Industrial Crystallization Technology, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China.,Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Tianjin 300072, China
| | - Hongxun Hao
- National Engineering Research Center of Industrial Crystallization Technology, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China.,Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Tianjin 300072, China
| |
Collapse
|
5
|
Aucamp M, Milne M. The physical stability of drugs linked to quality-by-design (QbD) and in-process technology (PAT) perspectives. Eur J Pharm Sci 2019; 139:105057. [PMID: 31470099 DOI: 10.1016/j.ejps.2019.105057] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2019] [Revised: 06/11/2019] [Accepted: 08/25/2019] [Indexed: 11/26/2022]
Abstract
The physical stability of solid-state forms in which drugs may exist is in some sense an overlooked aspect. In an era where strategies such as amorphous solid dispersions or co-amorphous preparations might provide answers to stumbling blocks such as poor drug solubility and bioavailability, the physical stability of such solid-state preparations should be a priority. Furthermore, the pharmaceutical industry is moving towards adapting a real time release of pharmaceutical products strategy, through the utilization of process analytical technology. It is thus becoming imperative to investigate the various types of phase transformations a specific solid-state form of a drug may undergo. Also, to critically assess the applicability of process analytical tools that may be sensitive enough to monitor not only chemical but also physical drug stability. These combined efforts allow quality to be built into the product, rather than dealing with costly post batch release recalls. Given that drug stability is an essential quality attribute for a drug product and the quality-by-design approach (QbD) is a best solution to build quality in all pharmaceutical products we focussed on the critical material attributes (CMAs), specifically relating to the physical stability of any given drug. This review highlights physical drug stability in relation to CMAs and how this ultimately link to the finished pharmaceutical product. Investigated challenges associated current PAT strategies is also discussed.
Collapse
Affiliation(s)
- Marique Aucamp
- School of Pharmacy, University of the Western Cape, Bellville, Cape Town 7535, South Africa.
| | - Marnus Milne
- School of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa, Pretoria 0204, South Africa
| |
Collapse
|
6
|
Inoue M, Hisada H, Koide T, Fukami T, Roy A, Carriere J, Heyler R. Transmission Low-Frequency Raman Spectroscopy for Quantification of Crystalline Polymorphs in Pharmaceutical Tablets. Anal Chem 2019; 91:1997-2003. [PMID: 30606009 DOI: 10.1021/acs.analchem.8b04365] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
The purpose of this study was to quantify polymorphs of active pharmaceutical ingredients in pharmaceutical tablets using a novel transmission low-frequency Raman spectroscopy method. We developed a novel transmission geometry for low-frequency Raman spectroscopy and compared quantitative ability in transmission mode versus backscattering mode using chemometrics. We prepared two series of tablets, (1) containing different weight-based contents of carbamazepine form III and (2) including different ratios of carbamazepine polymorphs (forms I/III). From the relationship between the contents of carbamazepine form III and partial least-squares (PLS) predictions in the tablets, correlation coefficients in transmission mode ( R2 = 0.98) were found to be higher than in backscattering mode ( R2 = 0.97). The root-mean-square error of cross-validation (RMSECV) of the transmission mode was 3.9 compared to 4.9 for the backscattering mode. The tablets containing a mixture of carbamazepine (I/III) polymorphs were measured by transmission low-frequency Raman spectroscopy, and it was found that the spectral shape changed according to the ratio of polymorphs: the relationship between the actual content and the prediction showed high correlation. These findings indicate that transmission low-frequency Raman spectroscopy possesses the potential to complement existing analytical methods for the quantification of polymorphs.
Collapse
Affiliation(s)
- Motoki Inoue
- Department of Molecular Pharmaceutics , Meiji Pharmaceutical University , 2-522-1, Noshio , Kiyose , Tokyo 204-8588 , Japan
| | - Hiroshi Hisada
- Department of Molecular Pharmaceutics , Meiji Pharmaceutical University , 2-522-1, Noshio , Kiyose , Tokyo 204-8588 , Japan
| | - Tatsuo Koide
- Division of Drugs , National Institute of Health Sciences , 3-25-26, Tonomachi , Kawasaki-ku, Kawasaki , Kanagawa 210-9501 , Japan
| | - Toshiro Fukami
- Department of Molecular Pharmaceutics , Meiji Pharmaceutical University , 2-522-1, Noshio , Kiyose , Tokyo 204-8588 , Japan
| | - Anjan Roy
- Ondax Incorporated , 850 East Duarte Road , Monrovia , California 91016 , United States
| | - James Carriere
- Ondax Incorporated , 850 East Duarte Road , Monrovia , California 91016 , United States
| | - Randy Heyler
- Ondax Incorporated , 850 East Duarte Road , Monrovia , California 91016 , United States
| |
Collapse
|
7
|
Elisei E, Willart JF, Danède F, Siepmann J, Siepmann F, Descamps M. Crystalline Polymorphism Emerging From a Milling-Induced Amorphous Form: The Case of Chlorhexidine Dihydrochloride. J Pharm Sci 2018; 107:121-126. [DOI: 10.1016/j.xphs.2017.07.003] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2017] [Revised: 06/15/2017] [Accepted: 07/06/2017] [Indexed: 11/16/2022]
|
8
|
Li Z, Zhao L, Lin X, Shen L, Feng Y. Direct compaction: An update of materials, trouble-shooting, and application. Int J Pharm 2017; 529:543-556. [PMID: 28720538 DOI: 10.1016/j.ijpharm.2017.07.035] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2017] [Revised: 07/08/2017] [Accepted: 07/10/2017] [Indexed: 01/25/2023]
Abstract
Direct compaction (DC) is the preferred choice for tablet manufacturing; however, only less than 20% of active pharmaceutical ingredients could be compacted via DC as its high requirement for functional properties of materials. Materials with improper functionalities could lead to serious troubles during DC manufacturing, such as content non-uniformity, sticking, and capping, all of which profoundly affect the properties of final products and, thus, severely restrict the practical application of DC. With undoubted importance, these seem to be unexpectedly ignored by reviewers but not researchers in terms of many original research articles published recently. Therefore, as an informative supplement and update, this review mainly focused on trouble-shooting and application situation of DC, together with several newly reported materials.
Collapse
Affiliation(s)
- Zhe Li
- College of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China; Engineering Research Center of Modern Preparation Technology of TCM of Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China
| | - LiJie Zhao
- Engineering Research Center of Modern Preparation Technology of TCM of Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China
| | - Xiao Lin
- College of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China; Engineering Research Center of Modern Preparation Technology of TCM of Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China.
| | - Lan Shen
- College of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China
| | - Yi Feng
- Engineering Research Center of Modern Preparation Technology of TCM of Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China
| |
Collapse
|
9
|
Dispersive Raman Spectroscopy for Quantifying Amorphous Drug Content in Intact Tablets. J Pharm Sci 2017; 106:579-588. [DOI: 10.1016/j.xphs.2016.10.014] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2016] [Revised: 09/24/2016] [Accepted: 10/03/2016] [Indexed: 11/19/2022]
|
10
|
Juban A, Briancon S, Puel F. Processing-induced-transformations (PITs) during direct compression: impact of compression speeds on phase transition of caffeine. Drug Dev Ind Pharm 2016; 42:1857-64. [PMID: 27109544 DOI: 10.1080/03639045.2016.1179753] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
For pharmaceutical industry, understanding solid-phase transition of the active pharmaceutical ingredient (API) induced by the manufacturing process is a key issue. Caffeine was chosen as a model API since it exhibits a polymorphic transformation during tableting. This study investigated the impact of the compression speed on the phase transition of anhydrous Form I (CFI) into Form II. Tablets were made from pure CFI and binary mixtures of CFI/microcrystalline cellulose, with an electric press well instrumented at three different compression speeds (50, 500 and 4500 mm min(-1)). For each velocity of the mobile punch studied, tablets made from three compression pressures (50, 100 and 200 MPa) were analyzed. The determination of the CFI transition degree was performed using a Differential Scanning Calorimetry (DSC). The CFI transition degree was monitored during three months in order to obtain the transformation profile of the API in tablets and in uncompressed powder. The modeling of the profile with a stretched exponential kinetic law (Johnson-Mehl-Avrami model) was used for the identification of the transition mechanism. The direct compression process triggered the polymorphic transformation in tablet when a sufficient compression pressure is applied. The velocity of the punch did neither impact the transition degree just after compression nor the transformation profile. The transition mechanism remained driven by nucleation for several operating conditions. Consequently, the punch velocity is not a decisive process parameter for avoiding such phase transition in tableting. As already observed, the compression pressure did not influence the transition whatever the compression speed and the velocity.
Collapse
Affiliation(s)
- Audrey Juban
- a Univ Lyon, Universite Lyon 1, CNRS, UMR5007 , LAGEP, 43 bd du 11 Novembre 1918 , Lyon , France
| | - Stephanie Briancon
- a Univ Lyon, Universite Lyon 1, CNRS, UMR5007 , LAGEP, 43 bd du 11 Novembre 1918 , Lyon , France
| | - François Puel
- a Univ Lyon, Universite Lyon 1, CNRS, UMR5007 , LAGEP, 43 bd du 11 Novembre 1918 , Lyon , France ;,b LGPM, Laboratoire de Génie des Procédés et Matériaux, CentraleSupélec, Université Paris-Saclay, Grande Voie des Vignes , Châtenay-Malabry , France
| |
Collapse
|